Temporal Trends and Outcomes Among Patients Admitted for Immune‐Related Adverse Events: A Single‐Center Retrospective Cohort Study from 2011 to 2018

BACKGROUND: The aim of this study was to characterize severe immune‐related adverse events (irAEs) seen among hospitalized patients and to examine risk factors for irAE admissions and clinically relevant outcomes, including length of stay, immune checkpoint inhibitor (ICI) discontinuation, readmissi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Molina, Gabriel E., Zubiri, Leyre, Cohen, Justine V., Durbin, Sienna M., Petrillo, Laura, Allen, Ian M., Murciano‐Goroff, Yonina R., Dougan, Michael, Thomas, Molly F., Faje, Alexander T., Rengarajan, Michelle, Guidon, Amanda C., Chen, Steven T., Okin, Daniel, Medoff, Benjamin D., Nasrallah, Mazen, Kohler, Minna J., Schoenfeld, Sara R., Karp Leaf, Rebecca S., Sise, Meghan E., Neilan, Tomas G., Zlotoff, Daniel A., Farmer, Jocelyn R., Mooradian, Meghan J., Bardia, Aditya, Mai, Minh, Sullivan, Ryan J., Semenov, Yevgeniy R., Villani, Alexandra Chloé, Reynolds, Kerry L.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
Immuno‐oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176966/
https://ncbi.nlm.nih.gov/pubmed/33655682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13740
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares